Primate adult brain cell autotransplantation produces behavioral and biological recovery in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian St. Kitts monkeys

Journal of Comparative Neurology

Volumn 522, Issue 12, 2014, Pages 2729-2740

  Bloch, Jocelyne ^a   Brunet, Jean François ^a   McEntire, Caleb R S ^b   Eugene Redmond, D ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOUBLECORTIN; GLIAL FIBRILLARY ACIDIC PROTEIN; NESTIN; NEUROFILAMENT PROTEIN; VIMENTIN; ORGANIC COMPOUND; PKH67; TYROSINE 3 MONOOXYGENASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; BEHAVIOR CHANGE; BRAIN CELL; BRAIN CELL AUTOTRANSPLANTATION; BRAIN CORTEX; CELL CULTURE; CELL SURVIVAL; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS STRIATUM; GRAFT SURVIVAL; HAPLORHINI; HISTOLOGY; MALE; MPTP-INDUCED PARKINSONISM; NERVE CELL; NONHUMAN; REIMPLANTATION; ST. KITTS MONKEY; STEREOLOGY; TYROSINE HYDROXYLASE NEURON; ANIMAL; BIOPSY; BRAIN; CELL COUNT; CHLOROCEBUS AETHIOPS; COMPLICATION; CONVALESCENCE; CYTOLOGY; DIAGNOSTIC USE; DISEASE MODEL; MENTAL DISORDERS; METABOLISM; MPTP POISONING; NECROSIS; PHYSIOLOGY; PROCEDURES; STATISTICAL MODEL; TIME; TRANSPLANTATION;

ANIMALS; BIOPSY; BRAIN; CELL COUNT; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; LINEAR MODELS; MALE; MENTAL DISORDERS; MPTP POISONING; NECROSIS; NEURONS; ORGANIC CHEMICALS; RECOVERY OF FUNCTION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TYROSINE 3-MONOOXYGENASE;

EID: 84912033515     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23579     Document Type: Article

References (68)

1. Adrio F, Rodriguez-Moldes I, Anadon R. 2011. Distribution of glycine immunoreactivity in the brain of the Siberian sturgeon (Acipenser baeri): comparison with gammaaminobutyric acid. J Comp Neurol 519:1115-1142.
2. Beck KD, Knusel B, Hefti F. 1993. The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience 52:855-866.
3. Björklund A, Lindvall O. 2000. Cell replacement therapies for central nervous system disorders. Nat Neurosci 3:537-544.
4. Björklund A, Stenevi U. 1979. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177:555-560.
5. Björklund A, Dunnett SB, Brundin P, Stoessl AJ, Freed CR, Breeze RE, Levivier M, Peschanski M, Studer L, Barker R. 2003. Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol 2:437-445.
6. Björklund LM, Sanchez-Pernaute R, Chung S, Andersson T, Chen IY, McNaught KS, Brownell AL, Jenkins BG, Wahlestedt C, Kim KS, Isacson O. 2002. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 99:2344-2349.
7. Bloch J, Kaeser M, Sadeghi Y, Rouiller EM, Redmond DE Jr, Brunet JF. 2011. Doublecortin-positive cells in the adult primate cerebral cortex and possible role in brain plasticity and development. J Comp Neurol 519:775-789.
8. Bochorishvili G, Stornetta RL, Coates MB, Guyenet PG. 2012. Pre-Botzinger complex receives glutamatergic innervation from galaninergic and other retrotrapezoid nucleus neurons. J Comp Neurol 520:1047-1061.
9. Brundin P, Björklund A. 1987. Survival, growth and function of dopaminergic neurons grafted to the brain. Prog Brain Res 71:293-308.
10. Brunet JF, Pellerin L, Arsenijevic Y, Magistretti P, Villemure JG. 2002. A novel method for in vitro production of human glial-like cells from neurosurgical resection tissue. Lab Invest 82:809-812.
11. Brunet JF, Pellerin L, Magistretti P, Villemure JG. 2003. Cryopreservation of human brain tissue allowing timely production of viable adult human brain cells for autologous transplantation. Cryobiology 47:179-183.
12. Brunet JF, Rouiller E, Wannier T, Villemure JG, Bloch J. 2005. Primate adult brain cell autotransplantation, a new tool for brain repair? Exp Neurol 196:195-198.
13. Brunet JF, Redmond DE Jr, Bloch J. 2009. Primate adult brain cell autotransplantation, a pilot study in asymptomatic MPTP-treated monkeys. Cell Transplant 18:787-799.
14. Chen J, Li Y, Wang L, Lu M, Chopp M. 2002. Caspase inhibition by Z-VAD increases the survival of grafted bone marrow cells and improves functional outcome after MCAo in rats. J Neurol Sci 199:17-24.
15. Cho MS, Lee YE, Kim JY, Chung S, Cho YH, Kim DS, Kang SM, Lee H, Kim MH, Kim JH, Leem JW, Oh SK, Choi YM, Hwang DY, Chang JW, Kim DW. 2008. Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A 105:3392-3397.
16. Clarkson ED, Zawada WM, Bell KP, Esplen JE, Choi PK, Heidenreich KA, Freed CR. 2001. IGF-I and bFGF improve dopamine neuron survival and behavioral outcome in parkinsonian rats receiving cultured human fetal tissue strands. Exp Neurol 168:183-191.
17. Erdo F, Buhrle C, Blunk J, Hoehn M, Xia Y, Fleischmann B, Focking M, Kustermann E, Kolossov E, Hescheler J, Hossmann KA, Trapp T. 2003. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab 23:780-785.
18. Freed CR. 2002. Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease? Proc Natl Acad Sci U S A 99:1755-1757.
19. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S. 2001. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:710-719.
20. Friedman WJ, Olson L, Persson H. 1991. Cells that express brain-derived neurotrophic factor mRNA in the developing postnatal rat brain. Eur J Neurosci 3:688-697.
21. Fukuda H, Takahashi J, Watanabe K, Hayashi H, Morizane A, Koyanagi M, Sasai Y, Hashimoto N. 2006. Fluorescenceactivated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation. Stem Cells 24:763-771.
22. Funkiewiez A, Ardouin C, Cools R, Krack P, Fraix V, Batir A, Chabardes S, Benabid AL, Robbins TW, Pollak P. 2006. Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease. Mov Disord 21:1656-1662.
23. Gall CM, Gold SJ, Isackson PJ, Seroogy KB. 1992. Brainderived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons. Mol Cell Neurosci 3:56-63.
24. Gautron L, Lee C, Funahashi H, Friedman J, Lee S, Elmquist J. 2010. Melanocortin-4 receptor expression in a vagovagal circuitry involved in postprandial functions. J Comp Neurol 518:6-24.
25. Hayes L, Zhang Z, Albert P, Zervas M, Ahn S. 2011. Timing of sonic hedgehog and Gli1 expression segregates midbrain dopamine neurons. J Comp Neurol 519:3001-3018.
26. Hedlund E, Pruszak J, Ferree A, Vinuela A, Hong S, Isacson O, Kim KS. 2007. Selection of embryonic stem cell-derived enhanced green fluorescent protein-positive dopamine neurons using the tyrosine hydroxylase promoter is confounded by reporter gene expression in immature cell populations. Stem Cells 25:1126-1135.
27. Hutton JT, Morris JL. 1995. Long-acting levodopa preparations. In: Koller WC, Paulson G, editors. Therapy of Parkinson's disease, 2nd ed. New York: Mercel Dekker Inc. p 173-187.
28. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM. 1991. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-232.
29. Hyman C, Juhasz M, Jackson C, Wright P, Ip NY, Lindsay RM. 1994. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J Neurosci 14:335-347.
30. Isacson O. 2003. The production and use of cells as therapeutic agents in neurodegenerative diseases. Lancet Neurol 2:417-424.
31. Kaeser M, Brunet JF, Wyss A, Belhaj-Saif A, Liu Y, Hamadjida A, Rouiller EM, Bloch J. 2011. Autologous adult cortical cell transplantation enhances functional recovery following unilateral lesion of motor cortex in primates: a pilot study. Neurosurgery 68:1405-1416; discussion 1416-1407.
32. Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJ, Mufson EJ, Sanberg PR, Hauser RA, Smith DA, Nauert GM, Perl DP, et al. 1995. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118-1124.
33. Lawrence MS, Redmond DE Jr. 1991. MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys. Pharmacol Biochem Behav 38:869-874.
34. Lindvall O, Kokaia Z, Martinez-Serrano A. 2004. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med 10(Suppl):S42-S50.
35. Mercuri NB, Bernardi G. 2005. The "magic" of L-dopa: why is it the gold standard Parkinson's disease therapy? Trends Pharmacol Sci 26:341-344.
36. Morizane A, Li JY, Brundin P. 2008. From bench to bed: the potential of stem cells for the treatment of Parkinson's disease. Cell Tissue Res 331:323-336.
37. Morona R, Gonzalez A. 2008. Calbindin-D28k and calretinin expression in the forebrain of anuran and urodele amphibians: further support for newly identified subdivisions. J Comp Neurol 511:187-220.
38. Morrow BA, Roth RH, Redmond DE Jr, Sladek JR Jr, Elsworth JD. 2007. Apoptotic natural cell death in developing primate dopamine midbrain neurons occurs during a restricted period in the second trimester of gestation. Exp Neurol 204:802-807.
39. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. 2008. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146.
40. Park K, Ourednik J, Ourednik V, Taylor RM, Aboody KS, Auguste KI, Lachyankar MB, Redmond DE, Snyder EY. 2002. Global gene and cell replacement strategies via stem cells. Gene Ther 9:613-624.
41. Park S, Kim EY, Ghil GS, Joo WS, Wang KC, Kim YS, Lee YJ, Lim J. 2003. Genetically modified human embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson's disease. Neurosci Lett 353:91-94.
42. Perlow MJ, Freed WJ, Hoffer BJ, Seiger A, Olson L, Wyatt RJ. 1979. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204:643-647.
43. Quinn M, Mukhida K, Sadi D, Hong M, Mendez I. 2008. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease. Eur J Neurosci 27:43-52.
44. Redmond DE Jr. 2002. Cellular replacement therapy for Parkinson's disease-where we are today? Neuroscientist 8:457-488.
45. Redmond DE Jr. 2011. Behavioral assessment in the African green monkey after MPTP administration. In: Lane EL, Dunnett SB, editors. Animal models of movement disorders. Totowa, NJ: Humana Press. p 401-435.
46. Redmond DE, Sladek JR Jr, Roth RH, Collier TJ, Elsworth JD, Deutch AY, Haber S. 1986. Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet 1:1125-1127.
47. Redmond DEJ, Sladek JR, Spencer DD, Ourednik J, Ourednik V, Taylor RM, Aboody KS, Auguste KI, Lachyankar MB, Redmond DE, Snyder EY. 2001. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 345:146-147.
48. Remy S, Canova C, Daguin-Nerriere V, Martin C, Melchior B, Neveu I, Charreau B, Soulillou JP, Brachet P. 2001. Different mechanisms mediate the rejection of porcine neurons and endothelial cells transplanted into the rat brain. Xenotransplantation 8:136-148.
49. Richardson RM, Fillmore HL, Holloway KL, Broaddus WC. 2004. Progress in cerebral transplantation of expanded neuronal stem cells. J Neurosurg 100:659-671.
50. Rodriguez-Gomez JA, Lu JQ, Velasco I, Rivera S, Zoghbi SS, Liow JS, Musachio JL, Chin FT, Toyama H, Seidel J, Green MV, Thanos PK, Ichise M, Pike VW, Innis RB, McKay RD. 2007. Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 25:918-928.
51. Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA. 2006. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12:1259-1268.
52. Scherba G, Weigel RM, O'Brien WD Jr. 1991. Quantitative assessment of the germicidal efficacy of ultrasonic energy. Appl Environ Microbiol 57:2079-2084.
53. Seroogy KB, Lundgren KH, Tran TM, Guthrie KM, Isackson PJ, Gall CM. 1994. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J Comp Neurol 342:321-334.
54. Shaw VE, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, Mitrofanis J. 2010. Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment. J Comp Neurol 518:25-40.
55. Sinclair SR, Svendsen CN, Torres EM, Martin D, Fawcett JW, Dunnett SB. 1996. GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. Neuroreport 7:2547-2552.
56. Sladek JR Jr, Collier TJ, Elsworth JD, Roth RH, Taylor JR, Redmond DE Jr. 1998. Intrastriatal grafts from multiple donors do not result in a proportional increase in survival of dopamine neurons in nonhuman primates. Cell Transplant 7:87-96.
57. Sortwell CE, Pitzer MR, Collier TJ. 2000. Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival. Exp Neurol 165:268-277.
58. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
59. Taylor JR, Elsworth JD, Roth RH, Sladek JR, Redmond DE Jr. 1994. Behavioral effects of MPTP administration in the vervet monkey: a primate model of Parkinson's disease. In: Toxin-induced models of neurological disorders. New York: Plenum Press. p 139-174.
60. Theus MH, Wei L, Cui L, Francis K, Hu X, Keogh C, Yu SP. 2008. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp Neurol 210:656-670.
61. Timmer M, Grosskreutz J, Schlesinger F, Krampfl K, Wesemann M, Just L, Bufler J, Grothe C. 2006. Dopaminergic properties and function after grafting of attached neural precursor cultures. Neurobiol Dis 21:587-606.
62. Watson RA, Yeung TM. 2011. What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury? BMC Neurol 11:113.
63. Wei L, Cui L, Snider BJ, Rivkin M, Yu SS, Lee CS, Adams LD, Gottlieb DI, Johnson EM Jr, Yu SP, Choi DW. 2005. Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiol Dis 19:183-193.
64. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R. 2007. In vitro reprogramming of fibroblasts into a pluripotent ES-celllike state. Nature 448:318-324.
65. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R. 2008. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A 105:5856-5861.
66. Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ. 2008. Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Parkinsonism Rel Disord 14:114-119.
67. Willerth S, Schaffer D. 2011. 5.508-Scaffold materials for hES cell culture and differentiation. In: Ducheyne P, editor. Comprehensive biomaterials. Berkeley, CA: University of California, Berkeley.
68. Zawada WM, Zastrow DJ, Clarkson ED, Adams FS, Bell KP, Freed CR. 1998. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res 786:96-103.